Stay updated with breaking news from Nasdaq Entx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Entera Bio (NASDAQ:ENTX – Get Free Report) and Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership. Earnings & Valuation This table compares Entera […]
Entera Bio Ltd. (NASDAQ:ENTX – Get Free Report) was the target of a significant drop in short interest during the month of December. As of December 15th, there was short interest totalling 59,400 shares, a drop of 13.0% from the November 30th total of 68,300 shares. Approximately 0.3% of the company’s shares are sold short. […]
Entera Bio Ltd. (NASDAQ:ENTX – Get Free Report) CEO Miranda Jayne Toledano bought 23,952 shares of the stock in a transaction that occurred on Friday, December 22nd. The shares were bought at an average price of $0.71 per share, for a total transaction of $17,005.92. Following the completion of the transaction, the chief executive officer […]
JERUSALEM, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered...
Entera Bio Ltd. (NASDAQ:ENTX – Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 50,300 shares, a growth of 89.1% from the August 31st total of 26,600 shares. Currently, 0.2% of the shares of the stock are short sold. Based […]